Warning letter
JW Nutritional LLC: warning letter of Apr 15, 2026
FDA warning letter 722096 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 722096 |
|---|---|
| Company | JW Nutritional LLC |
| Subject | CGMP/OTC Finished Pharmaceuticals/Adulterated |
| Issue date | Apr 15, 2026 |
| Posted date | May 19, 2026 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 211.84(d)(2), 211.100(a), 211.160(b) |
| Inspection city | Mckinney |
| Inspection ZIP | 75070 |
| Inspection start date | Sep 22, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: